<SEC-DOCUMENT>0001213900-24-064993.txt : 20240805
<SEC-HEADER>0001213900-24-064993.hdr.sgml : 20240805
<ACCEPTANCE-DATETIME>20240805073034
ACCESSION NUMBER:		0001213900-24-064993
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240805
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240805
DATE AS OF CHANGE:		20240805

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Actinium Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001388320
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				880378336
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36374
		FILM NUMBER:		241173101

	BUSINESS ADDRESS:	
		STREET 1:		100 PARK AVE., 23RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		(646) 677-3870

	MAIL ADDRESS:	
		STREET 1:		100 PARK AVE., 23RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cactus Ventures, Inc.
		DATE OF NAME CHANGE:	20070130
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0210560-8k_actinium.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:ATNM="http://actiniumpharma.com/20240805">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_030_ATNM_actiniumpharma.com_20240805 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20240805_20240805 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0001388320 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000004" name="dei:EntityCentralIndexKey">0001388320</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="atnm-20240805.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-08-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001388320</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-08-05</xbrli:startDate>
        <xbrli:endDate>2024-08-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES<br/>
SECURITIES AND EXCHANGE COMMISSION<br/>
Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM <span id="xdx_901_edei--DocumentType_c20240805__20240805_zowBVmjwJVd8"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Pursuant to Section 13 or 15(d) of the<br/>
Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_90C_edei--DocumentPeriodEndDate_c20240805__20240805_zkXAYAuFQDb5"><ix:nonNumeric contextRef="AsOf2024-08-05" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">August 5, 2024</ix:nonNumeric></span> </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_908_edei--EntityRegistrantName_c20240805__20240805_zmO8Wjbgzyca"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000011" name="dei:EntityRegistrantName">ACTINIUM PHARMACEUTICALS, INC.</ix:nonNumeric></span><br/>
(Exact name of registrant as specified in its charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_904_edei--EntityIncorporationStateCountryCode_c20240805__20240805_zozHkmxrS0Fj"><ix:nonNumeric contextRef="AsOf2024-08-05" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_904_edei--EntityFileNumber_c20240805__20240805_zBRCGXjpspmi"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000013" name="dei:EntityFileNumber">001-36374</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20240805__20240805_z347JNh3DWl5"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000014" name="dei:EntityTaxIdentificationNumber">74-2963609</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-size: 10pt"><b>(State or other jurisdiction<br/>
of incorporation)</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>(Commission File Number)</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>(IRS Employer<br/>
Identification No.)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_90C_edei--EntityAddressAddressLine1_c20240805__20240805_zrtAlowLNaZf"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000015" name="dei:EntityAddressAddressLine1">100 Park Ave.</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressAddressLine2_c20240805__20240805_zs4iMjOimZZ4"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000016" name="dei:EntityAddressAddressLine2">23rd Floor</ix:nonNumeric></span></b>, <b><span id="xdx_908_edei--EntityAddressCityOrTown_c20240805__20240805_zKuFuQ0FPpKi"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000017" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric></span></b>,
<b><span id="xdx_904_edei--EntityAddressStateOrProvince_c20240805__20240805_zvjmW19olppa"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000018" name="dei:EntityAddressStateOrProvince">NY</ix:nonNumeric></span> <span id="xdx_904_edei--EntityAddressPostalZipCode_c20240805__20240805_z6QlW5Ou0ZXb"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000019" name="dei:EntityAddressPostalZipCode">10017</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Address of Principal Executive Offices)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Registrant&#8217;s telephone number: (<span id="xdx_908_edei--CityAreaCode_c20240805__20240805_zvsszwmVcuxl"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000020" name="dei:CityAreaCode">646</ix:nonNumeric></span>) <span id="xdx_905_edei--LocalPhoneNumber_c20240805__20240805_zoxTbVHqea9f"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000021" name="dei:LocalPhoneNumber">677-3870</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Former name or former address, if changed since
last report)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--WrittenCommunications_c20240805__20240805_zJMdJp5YLsc1"><ix:nonNumeric contextRef="AsOf2024-08-05" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-size: 10pt">Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--SolicitingMaterial_c20240805__20240805_zrLzj5sLYJl9"><ix:nonNumeric contextRef="AsOf2024-08-05" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to
Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--PreCommencementTenderOffer_c20240805__20240805_z9buYPF1DDk"><ix:nonNumeric contextRef="AsOf2024-08-05" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--PreCommencementIssuerTenderOffer_c20240805__20240805_zHyt4jWxb1A7"><ix:nonNumeric contextRef="AsOf2024-08-05" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font-size: 10pt">Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt">Title of each class</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90E_edei--Security12bTitle_c20240805__20240805_zgtvNIZsbRB6"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000026" name="dei:Security12bTitle">Common Stock, par value $0.001 per share</ix:nonNumeric></span></b></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b><span id="xdx_908_edei--TradingSymbol_c20240805__20240805_zOtzZ5tVq614"><ix:nonNumeric contextRef="AsOf2024-08-05" id="Fact000027" name="dei:TradingSymbol">ATNM</ix:nonNumeric></span></b></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b><span id="xdx_907_edei--SecurityExchangeName_c20240805__20240805_z5ZF6NUCCBA6"><ix:nonNumeric contextRef="AsOf2024-08-05" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">NYSE American</ix:nonNumeric></span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_edei--EntityEmergingGrowthCompany_c20240805__20240805_zieKdXNKSC7l"><ix:nonNumeric contextRef="AsOf2024-08-05" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"> <b>Item 7.01</b> <b>Regulation FD Disclosure.</b></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 5, 2024, Actinium Pharmaceuticals, Inc.
(the &#8220;Company&#8221;) issued a press release announcing a regulatory update on the Company&#8217;s planned Biologics License Application
(&#8220;BLA&#8221;) filing for Iomab-B in patients with active relapsed or refractory acute myeloid leukemia (r/r AML). A copy of the
press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. The Company undertakes no obligation to update, supplement
or amend the materials attached hereto as Exhibit 99.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with General Instruction B.2 of
Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221;
for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject
to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities
Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing. Furthermore, the furnishing of information
under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained
herein, including the exhibits hereto, is material or that the dissemination of such information is required by Regulation FD.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>Item 9.01</b></span> <span style="font-size: 10pt"><b>Financial Statements and Exhibits</b>.</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 9%"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 90%"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td><a href="ea021056001ex99-1_actinium.htm"><span style="font-size: 10pt">Press Release, dated August 5, 2024<span style="text-decoration: underline">.</span></span></a></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt"><b>Actinium Pharmaceuticals, Inc.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">Date: August 5, 2024</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid"><span style="font-size: 10pt"><i>/s/ Sandesh Seth</i></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 5%"><span style="font-size: 10pt">Name: </span></td>
    <td style="width: 35%"><span style="font-size: 10pt">Sandesh Seth</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Title: </span></td>
    <td><span style="font-size: 10pt">Chairman and Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6PVxXFWSXDhVxigwRb4uLUtyakda/R/It7TbEEEjCOV+OELFY0dLUyHCalwUcsGlr7RFKvCCjPWNw5OtNBmGWeDXOs7a+P39gToHBwExHaqyD0FsfxmGVgZwlUiVqEpZMSdhvRdTpOdmLqdB6o2vQtoI9U8sGveb38OGgX2SpefdRR2RnyGaQjuQgf0DJVMGOHvpJfHNQFLmI4r4isWK6t8G1eHm0HQmLGpsQ5wb639EXBwBKjQ== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea021056001ex99-1_actinium.htm
<DESCRIPTION>PRESS RELEASE, DATED AUGUST 5, 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Actinium Provides Regulatory Update on Planned
BLA Filing and Future Plans for Iomab-B in the U.S.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: center; text-indent: -0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> - &nbsp;&nbsp;FDA determined that the Phase 3 SIERRA trial is not adequate to support a BLA filing for Iomab-B despite its statistically significant primary endpoint</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: center; text-indent: -0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> - &nbsp;&nbsp;Additional head-to-head randomized clinical trial demonstrating overall survival benefit with Iomab-B is required by FDA to support a BLA filing</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: center; text-indent: -0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> - &nbsp;&nbsp;Actinium to request a meeting with the FDA to further discuss specifics of additional trial</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: center; text-indent: -0.25in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> - &nbsp;&nbsp;Actinium will seek strategic partner for Iomab-B in the U.S. following completion of FDA interactions and focus<BR>
 development efforts on Actimab-A, Iomab-ACT and preclinical programs</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: center; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEW YORK, NY &ndash; August 05, 2024 &ndash; <B>Actinium
Pharmaceuticals, Inc.</B> (NYSE AMERICAN: ATNM) (&ldquo;Actinium&rdquo; or the &ldquo;Company&rdquo;), a leader in the development of
Antibody Radiation Conjugates (&ldquo;ARCs&rdquo;) and other targeted radiotherapies, today announced a regulatory update on the Company&rsquo;s
planned Biologics License Application (&ldquo;BLA&rdquo;) filing for Iomab-B in patients with active relapsed or refractory acute myeloid
leukemia (&ldquo;r/r AML&rdquo;). Iomab-B is an induction and conditioning targeted radiotherapy agent comprised of an anti-CD45 monoclonal
antibody and Iodine-131 radioisotope payload. The Company announced that it has now concluded both its clinical and Chemistry, Manufacturing
and Controls (&ldquo;CMC&rdquo;) interactions with the FDA regarding the BLA pathway for Iomab-B. Despite the SIERRA trial meeting the
primary endpoint of durable Complete Remission (&ldquo;dCR&rdquo;) with statistical significance (p-value&lt;0.0001) and other positive
secondary endpoints including Event Free Survival (&ldquo;EFS&rdquo;) and safety, the FDA has now determined that demonstrating an overall
survival benefit in a randomized head-to-head trial is required for a BLA filing. The FDA has advised Actinium to conduct a study to evaluate
allogeneic bone marrow transplant (BMT) using Iomab-B plus a reduced intensity conditioning regimen of fludarabine and total body irradiation
(&ldquo;Flu/TBI&rdquo;) versus allogeneic BMT using reduced intensity conditioning comprised of cyclophosphamide plus Flu/TBI, a difference
from the SIERRA trial, which had allowed physician&rsquo;s choice of salvage therapies and heterogenous conditioning regimens in the control
arm. Additionally, the proposed new study will not allow patients to crossover from the control arm which was allowed in the SIERRA trial
and confounded the overall survival analysis in the intent to treat (&ldquo;ITT&rdquo;) patient population, as nearly 60% of patients
crossed over from the control arm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Phase 3 SIERRA trial enrolled 153 patients
with r/r AML and compared outcomes of patients receiving Iomab-B and BMT to patients receiving physician&rsquo;s choice of care with salvage
chemotherapy and standard allogeneic BMT in the control arm. In February 2023, Actinium announced that the SIERRA trial met the primary
endpoint with statistical significance as 22% of patients (13/76) on the Iomab-B arm achieved dCR compared to 0% of patients (0/77) on
the control arm resulting in a p-value of &lt;0.0001. The SIERRA trial was conducted in accordance with guidance from the End of Phase
2 meeting with the FDA, which stated that positive results for dCR as the primary endpoint would be an acceptable endpoint to support
an Iomab-B BLA filing. SIERRA did not meet the secondary endpoint of overall survival on an intent to treat basis analysis due to the
high crossover rate with nearly 60% of control arm patients receiving Iomab-B followed by a BMT. Over the last several years, a majority
of therapies for patients with AML have been approved based on achieving a positive overall survival endpoint.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Actinium presented several additional analyses
from the SIERRA study to the FDA including long-term follow-up that demonstrated a trend towards improved overall survival and evidence
of survival benefit in patients with high-risk TP53 mutations to support Iomab-B&rsquo;s impact on overall survival. The SIERRA trial
data were presented in 12 oral presentations at several leading bone marrow transplant, hematology and nuclear medicine conferences in
both the U.S. and Europe, which Actinium believes demonstrates the high unmet medical need and scientific importance of Iomab-B&rsquo;s
ability to provide improved access and outcomes for patients with active r/r AML to the transplant community. However, the FDA has now
determined that the analyses from the SIERRA trial do not adequately support a BLA filing for Iomab-B and requires an additional clinical
study. Actinium expects the safety and efficacy data from the SIERRA trial will provide supportive evidence for a future Iomab-B BLA filing<B>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Key Outcomes and Implications of FDA Interactions
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify">Phase 3 SIERRA trial results are not adequate to support a BLA filing for Iomab-B in patients with active
r/r AML</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify">FDA is requiring an additional randomized head-to-head trial to demonstrate an overall survival benefit
evaluating allogeneic BMT using Iomab-B plus a reduced intensity conditioning regimen of fludarabine and total body irradiation (Flu/TBI)
to allogeneic BMT using reduced intensity conditioning comprised of cyclophosphamide plus Flu/TBI</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify">Proposed additional clinical trial to evaluate Iomab-B plus Flu/TBI compared to a single regimen comprised
of cyclophosphamide plus Flu/TBI which differs from the SIERRA trial that allowed physician&rsquo;s choice of salvage therapy and heterogenous
conditioning regimens in the control arm</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify">The proposed additional clinical trial will not allow crossover, which was allowed in SIERRA, and confounded
the overall survival analysis in the intent to treat (ITT) patient population as nearly 60% of patients crossed over from the control
arm</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify">Actinium intends to further discuss the specifics of the additional clinical trial including the patient
population, which the FDA has suggested could include all adult AML patients</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">-</TD><TD STYLE="text-align: justify">Upon conclusion of its interactions with the FDA, Actinium will seek a strategic partner for Iomab-B for
the U.S.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Avinash Desai, Actinium&rsquo;s Chief
Medical Officer, said, &ldquo;While this is not the outcome we expected, we will work with the FDA to further discuss specifics of
the proposed randomized head-to-head clinical study to determine its strategic feasibility. The 12 oral presentations of the SIERRA
results at prestigious bone marrow transplant, hematology and nuclear medicine medical conferences in the U.S. and EU are an
attestation of the strong interest from the transplant community for better conditioning regimens due to the high unmet need. We are
grateful to the patients, their families, as well as the study investigators and their staff who participated in the SIERRA trial.
As a first of its kind study, SIERRA broadened the investigation of Iomab-B as a targeted induction and conditioning agent from a
single center to twenty-four leading bone marrow transplant centers in North America, demonstrating its potential for the first time
in a randomized, controlled study. Through the conduct of SIERRA, Actinium also built strong relationships with key thought leaders.
This track record will provide a solid foundation to work with a partner on a subsequent Iomab-B trial, and we look forward to
finalizing the path forward for Iomab-B in the U.S. with the FDA.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Sandesh Seth, Actinium&rsquo;s Chairman and CEO,
said, &ldquo;We are disappointed that the positive results from the SIERRA trial are not deemed adequate by the FDA to support a BLA filing
despite meeting the primary endpoint with statistical significance and producing positive efficacy and safety outcomes on several measures.
SIERRA represented a first of its kind radiotherapeutic trial and demonstrated Actinium&rsquo;s ability to execute seamlessly across manufacturing,
supply chain, clinical development, and operations. We intend to leverage these capabilities as we continue to advance our highly differentiated
antibody radiation conjugate pipeline for cell &amp; gene therapy conditioning, hematology therapeutics and solid tumor candidates. We
are committed to establishing the best development path forward for Iomab-B in the U.S. and finding a partner, while keeping internal
resources and strategic priorities in focus.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Actinium Pharmaceuticals, Inc.</B></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal; font-weight: normal">Actinium
develops Antibody Radiation Conjugates (&ldquo;ARCs&rdquo;) and other targeted radiotherapies intended to meaningfully improve outcomes
for people who have failed existing oncology therapies. Iomab-B is an induction and conditioning agent prior to bone marrow transplant
in patients with relapsed and refractory acute myeloid leukemia (&ldquo;r/r AML&rdquo;), which Actinium plans to advance with a potential
strategic partner in the U.S. following completion of FDA interactions. The company continues to advance its development for product candidate
Actimab-A, a therapeutic agent that has demonstrated potential activity in r/r AML patients. In addition, Actinium is engaged with the
National Cancer Institute (&ldquo;NCI&rdquo;) under the Cooperative Research and Development Agreement (&ldquo;CRADA&rdquo;) for development
of Actimab-A in AML and other myeloid malignancies. Iomab-ACT, Actinium&rsquo;s next generation conditioning candidate, is being developed
with the goal of improving patient access and outcomes for potentially curative cell and gene therapies. In addition, the company&rsquo;s
R&amp;D efforts are primarily focused on advancing several preclinical programs for solid tumor indications. Actinium holds more than
235 patents and patent applications including several patents related to the manufacture of the isotope Ac-225 in a cyclotron.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal; font-weight: normal">For
more information, please visit:&nbsp;https://www.actiniumpharma.com/</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-style: normal">Forward-Looking Statements</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal; font-weight: normal">This
press release may contain projections or other &ldquo;forward-looking statements&rdquo; within the meaning of the &ldquo;safe-harbor&rdquo;
provisions of the private securities litigation reform act of 1995 regarding future events or the future financial performance of the
Company which the Company undertakes no obligation to update. These statements are based on management&rsquo;s current expectations and
are subject to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results,
including the risks and uncertainties associated with preliminary study results varying from final results, estimates of potential markets
for drugs under development, clinical trials, actions by the FDA and other governmental agencies, regulatory clearances, responses to
regulatory matters, the market demand for and acceptance of Actinium&rsquo;s products and services, performance of clinical research organizations
and other risks detailed from time to time in Actinium&rsquo;s filings with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;),
including without limitation its most recent annual report on form 10-K, subsequent quarterly reports on Forms 10-Q and Forms 8-K, each
as amended and supplemented from time to time.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal">Investors:</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal; font-weight: normal">investorrelations@actiniumpharma.com</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white">3</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "% B4# 2(  A$! Q$!_\0
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M0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:YBX^SLNYW/3"@=3[4QO&D=M?1V^HZ9=V*2_=DE Z>I'_P"NLJS _P"%J7&
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M.<_05G*K2D[0.NEA*\%[R_$T7UC1G^];6Y_[9_\ UJ#KNE*N%AB ]D->?_\
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M];[,CDKTKKF0VWU+; 5;J!69<S-<2$'G->.2>-[F]N[F:2>>,;C]GCCD*B,
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M@HHHI%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML&3X<>)VZ67_ )$'^-5)/AEXK;I8_P#D5?\ &NF/LNMC-\QO2>/-;7IK#?\
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M=%9,VLE=!CU2"RGG$D8<1)C(!&<D]@*Y[PKX@O[V>YDFLKBX%Q<#,L9'EP#
M&.3T'M51P\Y0E/HB)XVE"I"GUEKL]ON_KJ:NL>(;S3==L["'3FFBGQF09R<G
M!QVXZ\UT5<K>>+W@UFVTU=.FB:6559[CY?E)QE0,YKH-0U"UTNS>ZNY1'$G4
MGJ3Z =S3JTY)07+9M>MQ4*\'*H_:72?:W+IMT+5%<U<^*+FWT\:B=%N/L)P=
M[RJKX/0[>PK3M=<L;K1AJGF^7;8)8R<%2."#[YJ)4*D5=KK;Y]C6.*HRERJ6
MMK]M.^MM#2JK?W;65HTZVTUP5_Y9P@%C6)<>*98M._M./29WL.,2M(JD@G&=
MO)Q6SI^H0ZIID=Y;Y\N520&'([$&ATIP2E):7M_P CB*=1N$):VOMT[J^YE^
M&_$;>('O#]F$,<)4(-V6.<]?RKH*X/X<==4_WT_]FKH6UZ6XNKB#3-/>\%LV
MR63S5C7=_=&>IK?%4.6M*--:*WZ')@<4Y8:,ZKNW?YZOHO(VZ*R]&UE-8CG/
MV>6WEMY/+EBEQE36I7)*,H/EEN>C3J1J14HNZ85A>(-8O]%@:ZCLH)K1-H+&
M8JV2<=,?UK=KG/'/_(J7/^\G_H0K7#I2JQC)739SXR4H8><X.S2;^X7P]KVH
M:Z//.GPPV@8J9/.);('9<5T-<K\/O^1;/_7P_P#(4MYXXL8-2BLXE<_O=D\D
MJE0B]\#J36U;#N5>4*4=$<N&Q<886%7$3UE;?N^QU5%<K>>,_L+))/HU]':.
M<+.X"D_\!_QQ720W4,]HEU'(#"Z;PYX&W&<USSHS@DY+1G;2Q-*K)Q@]5_76
MQ-16!'XD>_\ .;2=-FO88B09BXC5CZ+GDU)H'B2VU]95CBDAFBQOC?T/<&FZ
M%11<FMM_+U%'%T9245+5[>=NSV9MT445B=(4444 %%%% !1110 4UUW(13J*
M / OB%K\\'C5[!P3:VJH1%V9F&2Q]>N/PK6^%GB>Y?7KK37)^Q21&5$)XC8$
M#CT!!Z>U=+XZ^'T/B*[2_CW)<J-I9/XAZ&L_PYX63PZSR!3YK\,QZX%>M"I&
MK2Y'N<$U[-W1Z@K!AD4ZN2E\3VNC1(U[-M#G:B@99SZ 5JZ/XFTS6Q(+2<^;
M%CS(G7:ZYZ$@]O>N"="<-;:'3"K&:-BBD# ]#2U@;!115>\OK:PM9;FYE6.&
M)2[NQX4#DFA*^PKV)R0!DUCZG?X1DC/-<4?BK;W[2O;V$@LHS_K6D =AZA<?
MIG-;<,@OD2:)M\<@#*P_B!Z&N^EAG'WIG'6K?9B>&ZCX>U.SUFXB6&61'D9D
M=1D,"<\^]>I> ;5O"?ARXFO\+<7$GF>63]T 8&?YUW%KHEN^))H@6^E>8?%/
M2-:>YBMH9E@TN<8+C.7?^X2.@]/7FJG5=5JE$J$>5<\CM_"?Q#TGQ/J%SI\$
MW^D0GY2>!*.Y3UQ74:C:K>6,T)_C1ER/<8KY5@LK[P_?PW,+F.6-@4D3C!KZ
M(\$>,8?$NFJLQ5+Z,8E3U_VA[5A6I>S=XFL)\ZLSP.X\,ZOIE_+8RVTI*,55
MU'RN.Q!KV7X=P2Z'X?AM9S\S.TC#T+'I797VCVMV3(T2E_7%8<UNUL^ N,=J
MZHU56ARR.:JI4W='5QR"10P-/KB;7QOI%I</!-=$K&VV214+(A]"PKLXI4FB
M26-E=' 964Y!!Z$&N"K2E3>IUTZBFCFO'W_(KR?]=H_YU6\(Z98ZGX3@6]M8
MI@DLFW>.1SV-:VM^'FUP[)M1N([?@^0BKMR._3)INC^''T8HD&J7+VZDDP.J
M[3G\,UV1K0CA?9J5I7OU_,\J>&J2QWMI0O#EY=U]]NQJ6>GVFGQ>5:6\<"9R
M0BXS]?6N*U[GXDZ6/^N?\VKOJYJY\(FZU1=2DU:Z^U(04<(GRXZ#&/>LL+5C
M&<I5'NFN^YMC\/.=*,*4=FGT6B=R/Q\/^*8?_KLG\Z=816,W@&U&I,5M%@5I
M"&(X!SVJ[J_A]M9M8K:XU&=8E WJJ+\[#^(\<?AQ2)X<3^P)-'FO)IK=@%1B
MJAHP.1C YY]:N-6"HQAS:J5_D1.A5>)G54;IPMJUOOKY=#$DOY=1\+7O]EVL
M=GI,,+HK2<O( .0J]OJ2:M?#[_D6V_Z^'_D*DTWP;'9PFWN-1N+FT+%OLQ^2
M,GW ZU)I/A)=(:=K?4;C+*5AR 1%G&3@\$\#FM*M6BZ<Z<7NTUH_Q\S"C0Q*
MK4ZTX[)IZK3T2TMT2^\P_"2)_P )GK*;%VXD&,<8WUV.I1I%H=XD:*B+;N J
MC 'RGM6/:>#C8WTE[;:O=I<29WOL0[LG)R"/6MG4K"34+(VRWDMN&&':-5)8
M8P1R.*RQ-2%2M&47IIWZ&^"H5:5"4)1UO)K5=;G.?#D?\2"?_KX/_H*U20 _
M%=L <#/_ )"KHM$\.?V&DD=OJ$[PN"?+=5P&X^;IG/%5/^$/;^U/[3_MB[%Y
M_P ]0B>F.F,=*V]O2]M5G?22:6CZG,L)76&HT^76#3>JZ7_S*?Q'4'1K5L<B
MXQG_ (":T;Y-,;PI9R:ON-K%'$Y4$C<VW ''7KTJ;6_#G]NI%'<7\Z11@'8B
MKAF_O'BDNO#:WN@C2[F]FE",#'*54,N. , 8(K.-6G[*G%RM9MNW9]C>="K[
M>K44$U**2O:S:[F#K%[=ZEX-GN(;>*STP*JQ1M\TDBA@!TX4?GTJ;37FC^&,
MC0$^8(9<$=0-QS^F:OVG@V**R^R7FH7-W;@$1Q$[40GN!ZCMGI5K0?#46B1R
MJ;F2YWC8!(.%7). /<GFM)UJ*I\L7M*ZT>O]=3&GA<2ZRJ35KP<7JM'W273L
ME\S,^'DT+:%+"A'FQS$N.^"!@_I^E;[6=E;W<]S!#"E_-&?F& [X_P BL1_!
M$,%Z;K2M0N-/<]53YACT'M['-:VFZ)'83O=2W$UW>.NTSSG)"^@'0"L<1.G.
M<JD);]+?GTL=.#IUJ=.-&I!>[UNK==5UO_5SB/ ]M%?7%[#/=74-Q\KXAF,9
M;DYSCK@_SKL(/#%A;ZG'J/F74ETAX>6<L3QC!SUXJIJ'@NVN=1_M"RNYK&Y+
M;F:+D$]R/2K]AH/V:Y2ZO+ZYOKE 0C3-A4SUPHXS[UIB,1&HW4A.UUM;\/0P
MP>#G1BJ52FG9Z2OYWO;>_P OF<SK1_XN7IN?2/\ ]FK2^(3 >&T'<W"?R-7=
M=\+0:U<PW:W$EK=1 !98QG@'(X]JAO?"":A91PW>HW,\JN&,TF"<8/RJ.B__
M %JJ%>ES4IM_#HU;U%4PN(Y<13C&_/JG==DB>Q./ T1]+ _^@5D_#?\ Y UU
M_P!=_P#V45TMCI45C8&R$LTT.W9B9LX7&,#VK(TOP>-+N28=4N_LI<2?9U(4
M$CIN(ZC\LUDJM-TZD&]VFM/4V>'K1JT:BC?E33U75+_(R/% SX\T<?\ 7/\
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M*?*[DE%%%<9L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 (0",&JMAIEGID31V<"0JQW-CJQ]S
MU-6Z*=W:Q+C%M-K5!1112*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ ICQ)(,.@;ZBGT4 -5%0850![4ZBB@ HHHH **** "J.I
M:>M]",'9,G*..H-7J*$[:B:35F>=:QIJW<,JRILN(AE@.WN/:L#P;?ZBNO10
MZ; 9MW,REL(J=RQ[5ZGJFDQ:E"P#>5/M*I*!G&?4=Q[4W0M"LO#^GK:6:>\D
MC?>D;U)_SBO16+BJ3BU=L\+^S:GUGFYK16J[^G]=#2%+117G'O!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
&4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>atnm-20240805.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 86o5s7xRiXhun8uDb31cWaSDaaPty5BxuZkxsmx4HfnaLygmQOXmIy1wOZg2gesE -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:ATNM="http://actiniumpharma.com/20240805" elementFormDefault="qualified" targetNamespace="http://actiniumpharma.com/20240805">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://actiniumpharma.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="atnm-20240805_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="atnm-20240805_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>atnm-20240805_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>atnm-20240805_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://actiniumpharma.com/role/Cover" xlink:href="atnm-20240805.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://actiniumpharma.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140099892254448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 05, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  05,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ACTINIUM PHARMACEUTICALS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001388320<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">74-2963609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 Park Ave.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">23rd Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">677-3870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ATNM<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSEAMER<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" #0.P59!8+\A6D$   E$0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V8;V_J-A3&OXJ53=,F%?('"K0#I)32770+%Q6ZJV[:"Y,8L)K$N;8#[;??
M<: )Z\();R ..4]^/CYY?$)_+^2KVC*FR5L<)6I@;;5.;VU;!5L64]44*4O@
ME[60,=4PE!M;I9+1, ^*(]MSG(X=4YY8PWY^;BZ'?9'IB"=L+HG*XIC*]SL6
MB?W <JV/$T]\L]7FA#WLIW3#%DP_IW,)([M0"7G,$L5%0B1;#RS?O;WSKDU
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MTG1X#SY['R73>RHY_U=3_ 102P,$%     @ T#L%69>*NQS     $P(   L
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MU!Y:YU;*O8=7LN48<?R>Y0]02P,$%     @ T#L%620>FZ*M    ^ $  !H
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M_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%
M  @ T#L%60=!36*!    L0   !               ( !     &1O8U!R;W!S
M+V%P<"YX;6Q02P$"% ,4    " #0.P59G=,5T.\    K @  $0
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M<R\N<F5L<U!+ 0(4 Q0    ( - [!5FJQ"(6,P$  "("   /
M  "  7(0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #0.P59)!Z;HJT
M  #X 0  &@              @ '2$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    " #0.P5999!YDAD!  #/ P  $P
M@ &W$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   !%
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0210560-8k_actinium.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://actiniumpharma.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>atnm-20240805.xsd</File>
    <File>atnm-20240805_lab.xml</File>
    <File>atnm-20240805_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0210560-8k_actinium.htm">ea0210560-8k_actinium.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0210560-8k_actinium.htm": {
   "nsprefix": "ATNM",
   "nsuri": "http://actiniumpharma.com/20240805",
   "dts": {
    "schema": {
     "local": [
      "atnm-20240805.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "atnm-20240805_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "atnm-20240805_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea0210560-8k_actinium.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://actiniumpharma.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-08-05",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0210560-8k_actinium.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-08-05",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0210560-8k_actinium.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://actiniumpharma.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001213900-24-064993-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-24-064993-xbrl.zip
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M'E*9NJA<SHHL>/*4N.[9-NN$!N<[F8(%6Y&RZ&HF#;\!ZN(GF&C#C.XV8BD
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M.!!4=&[J<3% 6,-[$5<=RG$AL*H7]#5<T#0>SSND^H=BE*:KRA4@">9-,HW
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M;FTM,C R-# X,#4N>'-D4$L! A0#%     @ T#L%650J'^+^"@  @(8  !4
M             ( !6P,  &%T;FTM,C R-# X,#5?;&%B+GAM;%!+ 0(4 Q0
M   ( - [!5FM>)_\6P<  .%7   5              "  8P.  !A=&YM+3(P
M,C0P.# U7W!R92YX;6Q02P$"% ,4    " #0.P59QHB?/G,3   <90  &0
M            @ $:%@  96$P,C$P-38P+3AK7V%C=&EN:75M+FAT;5!+ 0(4
M Q0    ( - [!5E&99H1L!,  (51   >              "  <0I  !E83 R
M,3 U-C P,65X.3DM,5]A8W1I;FEU;2YH=&U02P4&      4 !0!8 0  L#T
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>ea0210560-8k_actinium_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="atnm-20240805.xsd" xlink:type="simple"/>
    <context id="AsOf2024-08-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001388320</identifier>
        </entity>
        <period>
            <startDate>2024-08-05</startDate>
            <endDate>2024-08-05</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-08-05" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-08-05" id="Fact000004">0001388320</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-08-05" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-08-05" id="Fact000010">2024-08-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-08-05" id="Fact000011">ACTINIUM PHARMACEUTICALS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-08-05" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-08-05" id="Fact000013">001-36374</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-08-05" id="Fact000014">74-2963609</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-08-05" id="Fact000015">100 Park Ave.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-08-05" id="Fact000016">23rd Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-08-05" id="Fact000017">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-08-05" id="Fact000018">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-08-05" id="Fact000019">10017</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-08-05" id="Fact000020">646</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-08-05" id="Fact000021">677-3870</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-08-05" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-08-05" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-08-05" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-08-05" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-08-05" id="Fact000026">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-08-05" id="Fact000027">ATNM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-08-05" id="Fact000028">NYSEAMER</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-08-05" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
